TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/7/25 17:18 | 4/3/25 | IBO | Impact Biomedical Inc. | NV | Health | Drug | Pharmaceutical Preparations | Chan Heng Fai Ambrose | U0 | D | S | -174 | 0.4950 | 0 | -352 | -100 | 0 | I | |||||||||||||||
4/4/25 17:15 | 4/2/25 | IBO | Impact Biomedical Inc. | TX | RlEst | RlEst | Real Estate | Chan Heng Fai Ambrose | U0 | DT | S.m | -1,123 | 0.6646 | 0 | -1,690 | -100 | 0 | I | |||||||||||||||
4/2/25 21:01 | 3/31/25 | IBO | Impact Biomedical Inc. | TX | RlEst | RlEst | Real Estate | Chan Heng Fai Ambrose | U0 | DT | S.m | -2,913 | 1.15 | 0 | -2,527 | -77 | 734 | I | |||||||||||||||
12/4/23 21:30 | 11/30/23 | ACAX | Alset Capital Acquisition Corp. | DE | Retail | WhDrg | Drugs, Proprietaries & Druggi | Chan Heng Fai Ambrose | U0 | DOT | CEO | S | -428 | 10.60 | 0 | -40 | -8 | 485 | I | ||||||||||||||
10/19/22 21:55 | 10/17/22 | VEII | Value Exchange International, Inc. | DE | BizSv | Conslt | Management Consulting Service | Chan Heng Fai Ambrose | U0 | DT | S | -1,744 | 0.2397 | 0 | -7,276 | -34 | 13,871 | M |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |